Switch to
View more

IPCA Laboratories Ltd

IPCALAB
Health CarePharmaceuticals
MidcapWith a market cap of ₹23,545 cr, stock is ranked 203
Low RiskStock is 1.59x as volatile as Nifty
928.0588.25 (-8.68%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹23,545 cr, stock is ranked 203
Low RiskStock is 1.59x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
26.63
PB RatioPB Ratio
4.23
Dividend YieldDiv. Yield
0.86%
Sector PESector PE
38.16
Sector PBSector PB
4.82
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

43%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs).

Financial TrendFinancial statements 

20192020202120223.804.695.485.900.440.611.140.88
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 1.20%

See detailed holdings

Recent EventsAll events 

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnAug 12, 2022

IPCA Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

IPCA Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Newspaper Advertisements 
Announced OnAug 11, 2022

IPCA Laboratories Limited has informed the Exchange about Newspaper Advertisements - Financial result published for the 1st quarter ended 30th June, 2022 in newspapers. | Download

IPCA Laboratories Limited has informed the Exchange about Newspaper Advertisements - Financial result published for the 1st quarter ended 30th June, 2022 in newspapers. | Download

Cash Dividend 
Ex. DateNov 22, 2021

Interim • Div/Share: ₹ 8

See all events